Developing Curative Medicines for Neurodegenerative Diseases

Apr 7, 2023

Our CEO, Beth Hoffman, shares some of her insights into how to approach novel CNS targets by targeting the root cause in order to to slow or halt disease progression on pg. 24 of the latest issue of California Life Sciences digital magazine, Life Sciences Insights.

Read Article

About Cookies

About Cookies

Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.

Necessary

Always Active

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Name	Domain	Purpose	Expiry	Type
wpl_user_preference	origamitherapeutics.com	WP GDPR Cookie Consent Preferences	1 year	HTTP

Marketing

Marketing

Marketing

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Analytics

Analytics

Analytics

Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Preferences

Preferences

Preferences

Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Unclassified

Unclassified

Unclassified

Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.

Developing Curative Medicines for Neurodegenerative Diseases

Recent Posts

Recent Comments